| 000 | 00783cam a2200241 a 4500 | ||
|---|---|---|---|
| 999 |
_c5106 _d5106 |
||
| 001 | 14814 | ||
| 003 | BD-DhUAP | ||
| 005 | 20201220140822.0 | ||
| 008 | 201130s1991 ii abf b f000 0 eng | ||
| 020 | _a0824784847 | ||
| 040 |
_aBD-DhUAP _cBD-DhUAP _dBD-DhUAP _bEng |
||
| 082 |
_a615.58 PHA _223 |
||
| 245 |
_aPharmaceutical bioequivalence / _cedited by Peter G. Welling ... [et al.]. |
||
| 260 |
_aNew York : _bMarcel Dekker, _c©1991 [Reprinted 2006]. |
||
| 300 |
_aix, 467 pages : _billustrations ; _c23 cm. |
||
| 490 |
_aDrugs and the pharmaceutical sciences ; _v48. |
||
| 500 | _aIncludes index. | ||
| 650 |
_aDrugs _vBioavailability. |
||
| 650 |
_aDrugs _vTherapeutic equivalency. |
||
| 650 | _aBiological Availability. | ||
| 700 | _aWelling, Peter G. | ||
| 942 |
_2ddc _cBK |
||